Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 116 entries
View as:

Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03253848 Org: User:
Start: 09/26/17 End: 12/31/25 Due: 12/31/26

Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT01505712 Org: User:
Start: 12/15/11 End: 11/19/12 Due: 11/19/13

Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel

Phase: N/A Priority: Normal
NCT ID: NCT00900172 Org: User:
Start: 03/15/08 End: 04/15/09 Due: 04/15/10

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Phase: N/A Priority: Normal
NCT ID: NCT04566328 Org: User:
Start: 02/24/21 End: 12/31/27 Due: 12/31/28

Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003298 Org: User:
Start: 06/01/99 End: 05/31/11 Due: 05/31/12

Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03516942 Org: User:
Start: 06/11/18 End: 09/01/28 Due: 09/01/29

Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01216683 Org: User:
Start: 02/09/11 End: 12/02/19 Due: 12/02/20

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Phase: N/A Priority: Normal
NCT ID: NCT07001748 Org: User:
Start: 08/19/25 End: 05/30/30 Due: 05/30/31

DNA Changes in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00899184 Org: User:
Start: 05/23/06 End: 05/30/07 Due: 05/30/08

Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02412670 Org: User:
Start: 08/27/15 End: 05/10/22 Due: 05/10/23

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT02201992 Org: User:
Start: 03/23/15 End: 05/01/36 Due: 05/01/37

DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00897936 Org: User:
Start: 03/23/06 End: 10/15/09 Due: 10/15/10

Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00008385 Org: User:
Start: 12/18/00 End: 11/30/19 Due: 11/30/20

MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

Phase: N/A Priority: Normal
NCT ID: NCT02352883 Org: User:
Start: 03/25/15 End: 11/30/27 Due: 11/30/28

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

Phase: N/A Priority: Normal
NCT ID: NCT04438382 Org: User:
Start: 01/07/21 End: 12/21/23 Due: 12/21/24

Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01824901 Org: User:
Start: 01/15/14 End: 04/30/15 Due: 04/30/16

DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00899366 Org: User:
Start: 12/28/06 End: 07/30/09 Due: 07/30/10

Study of DNA Samples From Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00898040 Org: User:
Start: 07/06/06 End: 01/01/07 Due: 01/01/08

Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02031536 Org: User:
Start: 04/10/14 End: 07/19/17 Due: 07/19/18

Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00898911 Org: User:
Start: 07/08/08 End: 04/08/12 Due: 04/08/13

Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04001829 Org: User:
Start: 08/09/19 End: 03/31/27 Due: 03/31/28

Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease

Phase: N/A Priority: Normal
NCT ID: NCT03516279 Org: User:
Start: 06/26/19 End: 08/31/31 Due: 08/31/32

Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate

Phase: N/A Priority: Normal
NCT ID: NCT01209299 Org: User:
Start: 01/19/12 End: 02/19/12 Due: 02/19/13

Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01013961 Org: User:
Start: 04/27/11 End: 04/14/15 Due: 04/14/16

Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01164228 Org: User:
Start: 09/17/10 End: 11/03/21 Due: 11/03/22